Marinobufagenin in hypertensive patients with obstructive sleep apnea. 2006

N E Zvartau, and A O Conrady, and Y V Sviryaev, and O P Rotari, and N K Merkulova, and A L Kalinkin, and E V Shlyakhto, and A Y Bagrov
Almazov Research Institute of Cardiology, Saint-Petersburg, Russia.

Although obstructive sleep apnea (OSA) is an independent risk factor for hypertension, the underlying mechanisms are not clearly understood. Apnea and hypopnea episodes during sleep lead to sympathoactivation, decrease plasma pH, and predispose to sodium and volume retention. We hypothesized that, the latter could stimulate digitalis-like natriuretic/vasopressor hormones, endogenous ouabain (EO) and marinobufagenin (MBG). Overnight polysomnography (Embletta) and 24 hrs blood pressure monitoring (SpaceLab 90207) was conducted in 52 consecutive patients with OSA (51 +/- 8 years; 40 males, 12 females) and in 48 age-matched hypertensive subjects without OSA. According to the polysomnography data, 17 patients had a mild degree of OSA (apnea/hypopnea index (AHI) 5-15), 17 patients-moderate (AHI 15-30) and 18 -severe OSA (AHI >30). Levels of MBG excretion co-varied with OSA severity (0.5 +/- 0.1, 0.9 +/- 0.04 and 1.2 +/- 0.06 nmoles per 24 hrs, respectively), while excretion of EO did not differ in patients with different degrees of OSA severity. Our observations suggest that MBG may be involved in the pathogenesis of hypertension in OSA, and may be a marker of OSA severity.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010042 Ouabain A cardioactive glycoside consisting of rhamnose and ouabagenin, obtained from the seeds of Strophanthus gratus and other plants of the Apocynaceae; used like DIGITALIS. It is commonly used in cell biological studies as an inhibitor of the NA(+)-K(+)-EXCHANGING ATPASE. Acocantherin,G-Strophanthin,Acolongifloroside K,G Strophanthin
D001795 Blood Pressure Determination Techniques used for measuring BLOOD PRESSURE. Blood Pressure Determinations,Determination, Blood Pressure
D002018 Bufanolides Cyclopentanophenanthrenes with a 6-membered lactone ring attached at the 17-position and SUGARS attached at the 3-position. They are found in BUFONIDAE and often possess cardiotonic properties. Bufadienolides
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D017286 Polysomnography Simultaneous and continuous monitoring of several parameters during sleep to study normal and abnormal sleep. The study includes monitoring of brain waves, to assess sleep stages, and other physiological variables such as breathing, eye movements, and blood oxygen levels which exhibit a disrupted pattern with sleep disturbances. Monitoring, Sleep,Somnography,Polysomnographies,Sleep Monitoring,Somnographies

Related Publications

N E Zvartau, and A O Conrady, and Y V Sviryaev, and O P Rotari, and N K Merkulova, and A L Kalinkin, and E V Shlyakhto, and A Y Bagrov
February 2004, Deutsche medizinische Wochenschrift (1946),
N E Zvartau, and A O Conrady, and Y V Sviryaev, and O P Rotari, and N K Merkulova, and A L Kalinkin, and E V Shlyakhto, and A Y Bagrov
June 2021, BMC cardiovascular disorders,
N E Zvartau, and A O Conrady, and Y V Sviryaev, and O P Rotari, and N K Merkulova, and A L Kalinkin, and E V Shlyakhto, and A Y Bagrov
December 2017, Revista da Associacao Medica Brasileira (1992),
N E Zvartau, and A O Conrady, and Y V Sviryaev, and O P Rotari, and N K Merkulova, and A L Kalinkin, and E V Shlyakhto, and A Y Bagrov
January 1998, European journal of clinical pharmacology,
N E Zvartau, and A O Conrady, and Y V Sviryaev, and O P Rotari, and N K Merkulova, and A L Kalinkin, and E V Shlyakhto, and A Y Bagrov
December 2022, Journal of clinical hypertension (Greenwich, Conn.),
N E Zvartau, and A O Conrady, and Y V Sviryaev, and O P Rotari, and N K Merkulova, and A L Kalinkin, and E V Shlyakhto, and A Y Bagrov
January 2024, Frontiers in endocrinology,
N E Zvartau, and A O Conrady, and Y V Sviryaev, and O P Rotari, and N K Merkulova, and A L Kalinkin, and E V Shlyakhto, and A Y Bagrov
September 2020, Internal and emergency medicine,
N E Zvartau, and A O Conrady, and Y V Sviryaev, and O P Rotari, and N K Merkulova, and A L Kalinkin, and E V Shlyakhto, and A Y Bagrov
January 2015, Advances in experimental medicine and biology,
N E Zvartau, and A O Conrady, and Y V Sviryaev, and O P Rotari, and N K Merkulova, and A L Kalinkin, and E V Shlyakhto, and A Y Bagrov
June 2010, Zhonghua xin xue guan bing za zhi,
N E Zvartau, and A O Conrady, and Y V Sviryaev, and O P Rotari, and N K Merkulova, and A L Kalinkin, and E V Shlyakhto, and A Y Bagrov
January 2015, International journal of cardiology,
Copied contents to your clipboard!